NO20034638L - Tre trinns omdannelse av beskyttet taxanester til paclitaxel - Google Patents

Tre trinns omdannelse av beskyttet taxanester til paclitaxel

Info

Publication number
NO20034638L
NO20034638L NO20034638A NO20034638A NO20034638L NO 20034638 L NO20034638 L NO 20034638L NO 20034638 A NO20034638 A NO 20034638A NO 20034638 A NO20034638 A NO 20034638A NO 20034638 L NO20034638 L NO 20034638L
Authority
NO
Norway
Prior art keywords
paclitaxel
step conversion
protected taxane
taxane ester
ester
Prior art date
Application number
NO20034638A
Other languages
English (en)
Other versions
NO20034638D0 (no
Inventor
Jan Zygmunt
James D Mcchesney
Original Assignee
Napro Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napro Biotherapeutics Inc filed Critical Napro Biotherapeutics Inc
Publication of NO20034638D0 publication Critical patent/NO20034638D0/no
Publication of NO20034638L publication Critical patent/NO20034638L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20034638A 2001-04-25 2003-10-17 Tre trinns omdannelse av beskyttet taxanester til paclitaxel NO20034638L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/843,235 US6452025B1 (en) 2001-04-25 2001-04-25 Three-step conversion of protected taxane ester to paclitaxel
PCT/US2002/013288 WO2002085879A1 (en) 2001-04-25 2002-04-25 Three-step conversion of protected taxane ester to paclitaxel

Publications (2)

Publication Number Publication Date
NO20034638D0 NO20034638D0 (no) 2003-10-17
NO20034638L true NO20034638L (no) 2003-12-02

Family

ID=25289410

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034638A NO20034638L (no) 2001-04-25 2003-10-17 Tre trinns omdannelse av beskyttet taxanester til paclitaxel

Country Status (8)

Country Link
US (1) US6452025B1 (no)
EP (1) EP1389196A4 (no)
JP (1) JP2004535385A (no)
CA (1) CA2445250A1 (no)
IL (1) IL158494A0 (no)
NO (1) NO20034638L (no)
NZ (1) NZ531445A (no)
WO (1) WO2002085879A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1599457A4 (en) * 2003-02-04 2008-05-07 Natural Pharmaceuticals Inc METHOD AND COMPOSITION FOR PREPARING A COMPOUND WITH AN ACTIVE BENZOYLATING ACTIVE INCLUDING RING CHLORINE-FREE ACTIVE

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601676B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
FR2629818B1 (fr) 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
USRE34277E (en) 1988-04-06 1993-06-08 Centre National De La Recherche Scientifique Process for preparing taxol
FR2629819B1 (fr) 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5136060A (en) 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
US5015744A (en) 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
FR2658513B1 (fr) 1990-02-21 1994-02-04 Rhone Poulenc Sante Procede de preparation de l'acide cis-beta-phenylglycidique-(2r,3r).
FR2680506B1 (fr) 1991-08-19 1994-09-02 Rhone Poulenc Rorer Sa Procede de preparation de derives de la beta-phenylisoserine et leur utilisation.
FR2687150B1 (fr) 1992-02-07 1995-04-28 Rhone Poulenc Rorer Sa Procede de preparation de derives du taxane.
US5319112A (en) * 1992-08-18 1994-06-07 Virgnia Tech Intellectual Properties, Inc. Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
EP1260507A1 (en) * 1993-02-05 2002-11-27 Bryn Mawr College Synthesis of taxol, analogs and intermediates with variable A-nng side chains
US5684175A (en) 1993-02-05 1997-11-04 Napro Biotherapeutics, Inc. C-2' hydroxyl-benzyl protected, N-carbamate protected (2R, 3S)- 3-phenylisoserine and production process therefor
US5675025A (en) * 1995-06-07 1997-10-07 Napro Biotherapeutics, Inc. Paclitaxel synthesis from precursor compounds and methods of producing the same
US5750737A (en) * 1996-09-25 1998-05-12 Sisti; Nicholas J. Method for paclitaxel synthesis
US5973170A (en) 1996-09-25 1999-10-26 Napro Biotherapuetics, Inc. C-7 metal alkoxides of baccatin III

Also Published As

Publication number Publication date
US6452025B1 (en) 2002-09-17
WO2002085879A1 (en) 2002-10-31
NZ531445A (en) 2004-06-25
IL158494A0 (en) 2004-05-12
NO20034638D0 (no) 2003-10-17
WO2002085879B1 (en) 2003-04-03
JP2004535385A (ja) 2004-11-25
CA2445250A1 (en) 2002-10-31
EP1389196A1 (en) 2004-02-18
EP1389196A4 (en) 2005-08-17

Similar Documents

Publication Publication Date Title
NO20040053L (no) Syntese av taxol forsterkende midler
ITMI20021228A1 (it) Composizioni di poliuretani reticolabili
IS2917B (is) Notkun breyttra sýklósporína til að meðhöndla HCV kvilla
DE60334973D1 (de) Aerosol-formulierungen von diisobutyryl apomorphine
NO20044259L (no) Topiske farmasoytiske sammensetninger inneholdende proantocyanidiner for behandling av dermatitt
AU2003247656A8 (en) Oxidation of organic compounds
DK1687066T3 (da) Fremgangsmåder til immunmodulering
NO20044916L (no) Preparater av sulfinylacetamid
NO20043937L (no) Anvendelse av vitamin D sammensetninger
NO20020742L (no) Innskrenkning av innretninger for å lyddempe operasjoner
NO20024236L (no) Behandling av psoriasis
NO20034638L (no) Tre trinns omdannelse av beskyttet taxanester til paclitaxel
FR2883297B1 (fr) Genes de la biosynthese de la monacoline k
NO20034639L (no) To-trinns-konvertering av beskyttet taxanester til paclitaxel
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
PT1231206E (pt) Composicoes estabilizadas de peroxidicarbonatos organicos
DE50214840D1 (de) Ethylestern
NO20054875D0 (no) Syntese av 2-klormetyl-6-metylbenzosyreestere
NO20033809D0 (no) Metronomisk dosering av taxaner
ATE451907T1 (de) Antiperspirans-spray-zusammensetzungen
FR2853910B1 (fr) Genes du psoriasis
IDP000026456A (id) Senyawa-senyawa siklopropanakarboksilat ester
CY2003001I1 (el) Τοπικες συνθεσεις μακρολιδιων
ITTO20020584A1 (it) Gioco apposizione di elementi trattati mediante floccaggio
SE0100839D0 (sv) Förebyggande medel mot klotter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application